FDA advisory panel rejects widespread Pfizer booster shotsFDA advisory panel rejects widespread Pfizer booster shotsFDA advisory panel rejects widespread Pfizer booster shots

FDA advisory panel rejects widespread Pfizer booster shots

The 16-2 vote was a blow to the Biden administration’s effort to shore up people’s protection against the virus amid the highly contagious delta variant.

from Section Page News - Modern Healthcare https://ift.tt/3hJu0Ps